Japan’s Nikkei Drops as Markets Await Key U.S. Inflation Data 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
Tabletop particle accelerator could transform medicine and materials science 
Oil Prices Rise as Ukraine Targets Russian Energy Infrastructure 
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit 
Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains 
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth 
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates 
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Visa to Move European Headquarters to London’s Canary Wharf 
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions 
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
